Fibrinolytic bleeding and its control
- 31 March 1964
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 67 (3) , 425-427
- https://doi.org/10.1016/0002-8703(64)90022-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- HEPARIN TREATMENT OF BLEEDING: Clinical ObservationsThe Lancet, 1963
- Fibrinolytic mechanisms and the development of thrombolytic therapyThe American Journal of Medicine, 1962
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. II. THE SIGNIFICANCE, MECHANISM AND CONSEQUENCES OF DEFECTIVE FIBRIN POLYMERIZATION*Journal of Clinical Investigation, 1962
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. III. DEMONSTRATION OF ABNORMAL CLOT STRUCTURE BY ELECTRON MICROSCOPY*Journal of Clinical Investigation, 1962
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. I. THE SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS*Journal of Clinical Investigation, 1962
- Inhibition of fibrin polymerization by fibrinogen proteolysis productsAmerican Journal of Physiology-Legacy Content, 1962
- Influence of pH, ionic strength, neutral ions, and thrombin on fibrin polymerizationAmerican Journal of Physiology-Legacy Content, 1962